Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yafei Biomedical Technology is a specialized biotechnology company focused on the development and manufacture of high-performance raw materials for the in vitro diagnostics (IVD) industry. The company leverages its proprietary protein expression and antibody development platforms to produce a comprehensive catalog of recombinant antigens and antibodies. Their products are essential components in diagnostic assays for infectious diseases, cardiac markers, inflammatory response, and tumor detection. In addition to its product catalog, Yafei provides contract research services, including custom protein purification and monoclonal antibody development, to support global healthcare and life science partners. The company is headquartered in Shanghai and serves a diverse clientele ranging from academic researchers to large-scale diagnostic manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yafei Biomedical Technology.